The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation

Eur J Intern Med. 2021 Jun:88:21-22. doi: 10.1016/j.ejim.2021.04.008. Epub 2021 Apr 30.

Authors

Trygve S Hall¹, Dan Atar²

Affiliations

¹ Department of Cardiology, Oslo University Hospital Ulleval, Oslo, Norway.
² Department of Cardiology, Oslo University Hospital Ulleval, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: dan.atar@medisin.uio.no.

PMID: 33934970
DOI: 10.1016/j.ejim.2021.04.008

No abstract available

Keywords: Acute coronary syndrome; Antithrombotic therapy; Atrial fibrillation; Percutaneous coronary intervention.

MeSH terms

Acute Coronary Syndrome* / complications
Acute Coronary Syndrome* / drug therapy
Anticoagulants / therapeutic use
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Coronary Artery Disease* / drug therapy
Fibrinolytic Agents / therapeutic use
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / therapeutic use
Stents

Substances

Anticoagulants
Fibrinolytic Agents
Platelet Aggregation Inhibitors